Stockscreener 앱 받기
101.33
1.76%
-1.82
시간 외 거래:
100.93
-0.40
-0.39%
전일 마감가:
$103.15
열려 있는:
$104.53
하루 거래량:
365.48K
Relative Volume:
0.61
시가총액:
$7.87B
수익:
-
순이익/손실:
$-224.29M
주가수익비율:
-25.98
EPS:
-3.9
순현금흐름:
$-185.06M
1주 성능:
+0.43%
1개월 성능:
+2.19%
6개월 성능:
+32.27%
1년 성능:
+24.73%
1일 변동 폭
$100.63
$106.57
1주일 범위
$98.65
$106.57
52주 변동 폭
$55.53
$113.02
Nuvalent Inc Stock (NUVL) Company Profile
명칭
Nuvalent Inc
전화
508-446-2272
주소
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Compare NUVL vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NUVL
Nuvalent Inc
|
101.33 | 8.01B | 0 | -224.29M | -185.06M | -3.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-24 | 개시 | Truist | Buy |
| 2025-11-12 | 개시 | Canaccord Genuity | Buy |
| 2025-10-16 | 재개 | Stifel | Buy |
| 2025-10-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-09-04 | 재개 | Guggenheim | Buy |
| 2025-09-03 | 개시 | Raymond James | Outperform |
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-03-14 | 업그레이드 | UBS | Neutral → Buy |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-10-24 | 개시 | UBS | Neutral |
| 2024-08-29 | 개시 | Barclays | Overweight |
| 2024-04-17 | 개시 | Jefferies | Buy |
| 2024-04-01 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-02-28 | 재개 | Guggenheim | Buy |
| 2024-02-23 | 개시 | Robert W. Baird | Outperform |
| 2023-09-27 | 개시 | Stifel | Buy |
| 2023-08-08 | 개시 | SVB Securities | Market Perform |
| 2023-07-24 | 개시 | Guggenheim | Buy |
| 2023-01-18 | 개시 | Wedbush | Outperform |
| 2022-06-24 | 개시 | BMO Capital Markets | Outperform |
모두보기
Nuvalent Inc 주식(NUVL)의 최신 뉴스
NUVL: Global launches of innovative ROS1 and ALK inhibitors drive growth and pipeline expansion - TradingView
Nuvalent honors women pioneers on Women in Science Day - Traders Union
Candriam S.C.A. Purchases 28,462 Shares of Nuvalent, Inc. $NUVL - MarketBeat
Assessing Nuvalent (NUVL) Valuation As DCF Signals Upside Versus Current Market Pricing - Yahoo Finance
US Stocks Recap: Is Nuvalent Inc forming a bullish divergenceJuly 2025 PostEarnings & Reliable Breakout Forecasts - baoquankhu1.vn
Nuvalent to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - Morningstar
Liquidity Mapping Around (NUVL) Price Events - Stock Traders Daily
Nuvalent, Inc. (NUVL) Investor Outlook: Biotechnology Innovator with a 37.73% Potential Upside - DirectorsTalk Interviews
Nuvalent, Inc. (NUVL): Investor Outlook With A 33% Potential Upside - DirectorsTalk Interviews
Nuvalent, Inc. (NASDAQ:NUVL) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Aug Final Week: Is Nuvalent Inc benefiting from innovation trendsBreakout Watch & Long-Term Growth Plans - baoquankhu1.vn
Why (NUVL) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Insider Selling: Nuvalent (NASDAQ:NUVL) Insider Sells 14,300 Shares of Stock - MarketBeat
Deborah Ann Miller Sells 700 Shares of Nuvalent (NASDAQ:NUVL) Stock - MarketBeat
Nuvalent Inc stock hits 52-week high at 112.89 USD By Investing.com - Investing.com Australia
Nuvalent (NASDAQ:NUVL) Reaches New 52-Week HighHere's Why - MarketBeat
Nuvalent Inc stock hits 52-week high at 112.89 USD - Investing.com
Market Trends: What analysts say about OSUR stockJuly 2025 Technicals & Fast Entry and Exit Trade Plans - baoquankhu1.vn
SG Americas Securities LLC Takes Position in Nuvalent, Inc. $NUVL - MarketBeat
Jefferies Keeps Their Buy Rating on Nuvalent (NUVL) - The Globe and Mail
Nuvalent (NASDAQ:NUVL) Stock Price Up 7.3%Here's Why - MarketBeat
Nuvalent stock jumps as FDA review clock sharpens focus on 2026 launch plans - TechStock²
FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment By Investing.com - Investing.com Nigeria
Understanding Momentum Shifts in (NUVL) - Stock Traders Daily
Nuvalent (NASDAQ:NUVL) Stock Price Down 6.7%What's Next? - MarketBeat
Nuvalent Announces OnTarget 2026 Operating Plan Progress and Outlines Key Anticipated 2026 Milestones - Investing News Network
Downgrade Watch: How buybacks impact Nuvalent Inc stock valueJuly 2025 Action & High Accuracy Buy Signal Tips - Bộ Nội Vụ
This Insider Has Just Sold Shares In Nuvalent - simplywall.st
Aug Intraday: Will Nuvalent Inc. stock outperform growth indexesJuly 2025 Chart Watch & Fast Entry High Yield Tips - Улправда
Will Nuvalent Inc. stock outperform tech sector in 2025Trend Reversal & Capital Efficient Trade Techniques - Улправда
How Nuvalent Inc. stock performs in weak economy2025 AllTime Highs & Low Risk Entry Point Guides - Улправда
Will Nuvalent Inc. stock return to pre crisis levelsJuly 2025 Snapshot & Real-Time Volume Trigger Notifications - Улправда
How buybacks impact Nuvalent Inc. stock valueRate Hike & Community Trade Idea Sharing Platform - Улправда
Is Nuvalent Inc. stock in correction or buying zone2025 Short Interest & AI Based Buy and Sell Signals - Улправда
Is Nuvalent Inc. stock a defensive play in 2025Dividend Hike & Daily Growth Stock Investment Tips - Улправда
Nuvalent (NUVL) chief development officer sells $721k in stock By Investing.com - Investing.com India
Nuvalent CSO Pelish sells shares worth $501,752 By Investing.com - Investing.com South Africa
Will Nuvalent’s Momentum Continue? - StocksToTrade
Nuvalent (NASDAQ:NUVL) Insider Sells $251,547.24 in Stock - MarketBeat
Nuvalent (NASDAQ:NUVL) CFO Sells $309,065.96 in Stock - MarketBeat
Insider Selling: Nuvalent (NASDAQ:NUVL) Insider Sells 2,496 Shares of Stock - MarketBeat
Nuvalent (NASDAQ:NUVL) Insider Sells $412,247.52 in Stock - MarketBeat
Nuvalent (NASDAQ:NUVL) Insider Sells $309,065.96 in Stock - MarketBeat
Nuvalent CSO Pelish sells shares worth $501,752 - Investing.com India
Nuvalent (NUVL) chief legal officer Miller sells $676k in stock By Investing.com - Investing.com South Africa
Nuvalent (NUVL) chief legal officer Miller sells $676k in stock - Investing.com Australia
Nuvalent Inc (NUVL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Nuvalent Inc 주식 (NUVL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Noci Darlene | Chief Development Officer |
Jan 29 '26 |
Sale |
102.08 |
5,500 |
561,422 |
58,117 |
| Miller Deborah Ann | Chief Legal Officer |
Jan 22 '26 |
Option Exercise |
27.85 |
14,300 |
398,255 |
73,934 |
| Miller Deborah Ann | Chief Legal Officer |
Jan 21 '26 |
Option Exercise |
27.85 |
700 |
19,495 |
60,334 |
| Miller Deborah Ann | Chief Legal Officer |
Jan 22 '26 |
Sale |
110.16 |
14,300 |
1,575,288 |
59,634 |
| Miller Deborah Ann | Chief Legal Officer |
Jan 21 '26 |
Sale |
109.84 |
700 |
76,888 |
59,634 |
1.24%
0.19%
자본화:
|
볼륨(24시간):